Cloud Banner

Healthcare

Image

Global Tissue Diagnostics Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Jun 2023
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Tissue Diagnostics Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 6.6000000000000005% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 530.60 Million
Diagram Market Size (Forecast Year) USD 884.76 Million
Diagram CAGR 6.6000000000000005%

Global Tissue Diagnostics Market, By Product (Consumables, Instruments), Technology (Immunohistochemistry, In Situ Hybridization, Digital Pathology and Workflow Management, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer, Other Diseases), End User (Hospitals, Pharmaceutical Companies, Research Laboratories, Diagnostic Centres, Ambulatory Surgical Centres, Others) - Industry Trends and Forecast to 2030.

Tissue Diagnostics Market Analysis and Size

Tissue diagnostics refers to the process of examining and analyzing tissue samples from the human body to diagnose diseases, determine their severity, and guide treatment decisions. It is an essential component of clinical pathology and plays a crucial role in the field of medicine. Tissue diagnostics play a vital role in the diagnosis of various conditions, including cancers, inflammatory disorders, infectious diseases, and autoimmune conditions. It provides valuable information to guide personalized treatment decisions and helps in assessing prognosis and predicting therapeutic responses.

Data Bridge Market Research analyses that the tissue diagnostics market which was USD 530.6 million in 2022, would rocket up to USD 884.76 million by 2030, and is expected to undergo a CAGR of 6.6% during the forecast period. This indicates that the market value of consumables dominates the product segment of the tissue diagnostics market owing to the growing prevalence of cancer cases. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Tissue Diagnostics Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2014-2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product (Consumables, Instruments), Technology (Immunohistochemistry, In Situ Hybridization, Digital Pathology and Workflow Management, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer, Other Diseases), End User (Hospitals, Pharmaceutical Companies, Research Laboratories, Diagnostic Centres, Ambulatory Surgical Centres, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

F. Hoffmann-La Roche Ltd (Switzerland), Danaher (U.S.), Thermo Fisher Scientific (U.S.),  Abbott (U.S.), Agilent Technologies Inc. (U.S.), Merck KGaA (U.S.), Sakura Finetek Japan Co. Ltd. (U.S.), BD (U.S.), QIAGEN (Germany), Bio SB (U.S.), BioGenex. (U.S.), Abcam plc. (U.K.), Cell Signaling Technology  Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), The Menarini Group (Italy), Enzo Life Sciences, Inc. (U.S.), Zenalux Biomedical, Inc. (U.S.), 3DHISTECH Ltd. (Hungary), Lunaphore Technologies (Switzerland), Biocare Medical, LLC. (U.S.),  Cernostics (U.S.),  and Genomic Health (U.S.)

Market Opportunities

  • Growing geriatric population
  • Evolution of Liquid biopsy technique

Market Definition

From the name itself, it is clear that tissue diagnostics are those diagnostic techniques that are used for the diagnosis of diseases using different tissues in the body. In this, a small piece of tissue is removed from the body and then analyzed further using a microscope and other techniques to detect the diseases such as cancer.

Tissue Diagnostics Market Dynamics

Drivers

  • Rising prevalence of cancers

The growing prevalence of cancer in the current world is directly influencing the demand for specific diagnostics that offer more precision. Tissue diagnostics being the specialized and precise diagnostics test is emerging as a promising technique. This in turn has carved the way for the growth of the market.  

  • Research and development proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies about the disease diagnostics will further create lucrative market growth opportunities. Research and development proficiencies being conducted to develop a better and precise diagnostic method are also boosting the market growth rate.

  • Growing investment in healthcare facilities  

Surging focus on improving the condition of healthcare facilities and improving the overall healthcare infrastructure is another important factor fostering the growth of the market. The rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.  

Opportunities

  • Growing geriatric population

The aging population is more susceptible to chronic diseases, including cancer. As the global population continues to age, there is an increasing demand for accurate and timely diagnosis, driving the tissue diagnostics market.

  • Evolution of Liquid biopsy technique

The emergence of liquid biopsy, a non-invasive diagnostic technique that detects genetic alterations and biomarkers in blood or other body fluids, presents an opportunity for the tissue diagnostics market. Liquid biopsy has the potential to complement traditional tissue-based diagnostics and enable real-time monitoring of disease progression.

Restraints/Challenges

  • Lack of skilled professionals

Performing tissue diagnostics requires specialized skills and expertise, particularly in areas such as histopathology, molecular pathology, and interpretation of results. The shortage of skilled pathologists, technicians, and molecular biologists can hinder the widespread adoption and efficient implementation of tissue diagnostics, leading to delays in diagnosis and treatment.

  • Stringent regulatory requirements

The tissue diagnostics market is subject to strict regulatory oversight, ensuring patient safety, accuracy, and quality of diagnostic tests. Obtaining regulatory approvals and complying with regulations can be time-consuming and costly, particularly for new diagnostic technologies and companion diagnostics. Stringent regulatory requirements may slow down the pace of innovation and market entry for new products.

This tissue diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the tissue diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In May 2022, Leica Biosystems (Nussloch, Germany) launched a compact, dual-retort tissue processor, the HistoCore PEGASUS Plus
  • In March 2021, Roche launched DISCOVERY Green HRP chromogen detection kit to expand immunohistochemistry multiplexing in cancer research

Global Tissue Diagnostics Market Scope

The tissue diagnostics market is segmented on the basis of product, technology, disease and end user . The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Consumables
  • Instruments

Technology

  • Immunohistochemistry
  • In Situ Hybridization
  • Digital Pathology and Workflow Management
  • Special Staining

Disease

  • Breast Cancer
  • Gastric Cancer
  • Lymphoma
  • Prostate Cancer
  • Non-Small Cell Lung Cancer
  • Other Diseases

End User

  • Hospitals
  • Pharmaceutical Companies
  • Research Laboratories
  • Diagnostic Centres
  • Ambulatory Surgical Centres
  • Others

Tissue Diagnostics Market Regional Analysis/Insights

The tissue diagnostics market is analysed and market size insights and trends are provided by country, product, technology, disease and end user  as referenced above.

The countries covered in the tissue diagnostics market report are U.S., Canada and Mexico in North America, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the tissue diagnostics market because of the rising prevalence of cancer in the region and growing investment in healthcare infrastructure. .   

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.     

Healthcare Infrastructure growth Installed base and New Technology Penetration

The tissue diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Tissue Diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Tissue Diagnostics market. The data is available for historic period 2010-2020.

Competitive Landscape and Tissue Diagnostics Market Share Analysis

The tissue diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to tissue diagnostics market.

Some of the major players operating in the tissue diagnostics market are:

  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Danaher (U.S.)
  • Thermo Fisher Scientific (U.S.)
  • Abbott (U.S.)
  • Agilent Technologies Inc. (U.S.)
  • Merck KGaA (U.S.)
  • Sakura Finetek Japan Co. Ltd. (U.S.)
  • BD (U.S.)
  • QIAGEN (Germany)
  • Bio SB (U.S.)
  • BioGenex. (U.S.)
  • Abcam plc. (U.K.)
  • Cell Signaling Technology  Inc. (U.S.)
  • Koninklijke Philips N.V. (Netherlands)
  • The Menarini Group (Italy)
  • Enzo Life Sciences, Inc. (U.S.)
  • Zenalux Biomedical, Inc. (U.S.)
  • 3DHISTECH Ltd. (Hungary)
  • Lunaphore Technologies (Switzerland)
  • Biocare Medical, LLC. (U.S.)
  • Cernostics (U.S.)
  • Genomic Health (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The tissue diagnostics market value was USD 530.6 million in 2022.
The tissue diagnostics market is projected to grow at a CAGR of 6.6% during the forecast period of 2023-2030.
The countries covered in the tissue diagnostics market report are U.S., Canada and Mexico in North America, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The tissue diagnostics market is segmented on the basis of product, technology, disease and end user .
North America dominates the tissue diagnostics market because of the rising prevalence of cancer in the region and growing investment in healthcare infrastructure.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials